{
    "root": "8ff1d6e9-b7ac-4b4f-af40-b1fb8a0809aa",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Glucagon",
    "value": "20230228",
    "ingredients": [],
    "indications": "glucagon injection antihypoglycemic agent gastrointestinal motility inhibitor indicated : • treatment severe hypoglycemia pediatric adult patients diabetes . ( 1.1 ) • diagnostic aid radiologic examinations temporarily inhibit movement gastrointestinal tract adult patients . ( 1.2 )",
    "contraindications": "adult pediatric patients treat severe hypoglycemia ( 2.2 ) • adults pediatric patients weighing 20 kg : ▪ recommended 1 mg ( 1 ml ) injected subcutaneously intramuscularly upper arm , thigh , buttocks , intravenously . ▪ response 15 minutes , additional 1 mg dose ( 1 ml ) may administered waiting emergency assistance . • pediatric patients weighing less 20 kg : ▪ recommended 0.5 mg ( 0.5 ml ) dose equivalent 20 mcg/kg 30 mcg/kg injected subcutaneously intramuscularly upper arm , thigh , buttocks , intravenously . ▪ response 15 minutes , additional 0.5 mg dose ( 0.5 ml ) may administered waiting emergency assistance . important instructions using glucagon injection treat severe hypoglycemia ( 2.1 ) • glucagon injection subcutaneous , intramuscular , intravenous injection . administer intravenously medical supervision . • full prescribing information instructions adults using glucagon injection diagnostic aid ( 2.4 ) • doses required relaxation stomach , duodenum , small bowel , depend onset duration effect required examination . • dose relaxation duodenum small bowel 0.25 mg 0.5 mg given intravenously 1 mg given intramuscularly . • stomach 0.5 mg intravenous 2 mg intramuscular doses recommended . • colon , recommended 2 mg dose administered intramuscularly approximately 10 minutes prior procedure . • full prescribing information instructions ( 2.3 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "glucagon injection contraindicated patients : •pheochromocytoma risk substantial increase blood pressure [ warning ( 5.1 ) ] •insulinoma risk hypoglycemia [ warning ( 5.2 ) ] •known hypersensitivity glucagon excipients glucagon injection . allergic reported glucagon include anaphylactic shock breathing difficulties hypotension [ warning ( 5.3 ) ] •glucagonoma used diagnostic aid risk hypoglycemia [ ( 5.8 ) ]",
    "indications_original": "Glucagon for Injection is an antihypoglycemic agent and a gastrointestinal motility inhibitor indicated: • for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. ( 1.1 ) • as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. ( 1.2 )",
    "contraindications_original": "Dosage in adult and pediatric patients to treat severe hypoglycemia ( 2.2 ) • Adults and Pediatric Patients Weighing 20 kg or More: ▪ The recommended dosage is 1 mg (1 mL) injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously. ▪ If there has been no response after 15 minutes, an additional 1 mg dose (1 mL) may be administered while waiting for emergency assistance. • Pediatric Patients Weighing Less Than 20 kg: ▪ The recommended dosage is 0.5 mg (0.5 mL) or dose equivalent to 20 mcg/kg to 30 mcg/kg injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously. ▪ If there has been no response after 15 minutes, an additional 0.5 mg dose (0.5 mL) may be administered while waiting for emergency assistance. Important Administration Instructions for Using Glucagon for Injection to Treat Severe Hypoglycemia ( 2.1 ) • Glucagon for Injection is for subcutaneous, intramuscular, or intravenous injection. Administer intravenously ONLY under medical supervision. • See the Full Prescribing Information for administration instructions Dosage in Adults for Using Glucagon for Injection as a Diagnostic Aid ( 2.4 ) • Doses required for relaxation of the stomach, duodenum, and small bowel, depend on the onset and duration of effect required for the examination. • The dose for relaxation of the duodenum and small bowel is 0.25 mg to 0.5 mg given intravenously or 1 mg given intramuscularly. • For the stomach 0.5 mg intravenous or 2 mg intramuscular doses are recommended. • For the colon, it is recommended that a 2 mg dose be administered intramuscularly approximately 10 minutes prior to the procedure. • See the Full Prescribing Information for administration instructions ( 2.3 )",
    "adverseReactions_original": "Glucagon for Injection is contraindicated in patients with: \n                  \n                     \n                        •Pheochromocytoma because of the risk of substantial increase in blood pressure [see Warning and Precautions (5.1)] \n                     \n                     \n                        •Insulinoma because of the risk of hypoglycemia [see Warning and Precautions (5.2)] \n                     \n                     \n                        •Known hypersensitivity to glucagon or any of the excipients in Glucagon for Injection. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [see Warning and Precautions (5.3)] \n                     \n                     \n                        •Glucagonoma when used as a diagnostic aid because of the risk of hypoglycemia [see Warnings and Precautions (5.8)]"
}